Bayer Ag Na Stock Earnings Per Share
| BAYN Stock | EUR 19.79 0.19 0.97% |
Bayer AG NA fundamentals help investors to digest information that contributes to Bayer AG's financial success or failures. It also enables traders to predict the movement of Bayer Stock. The fundamental analysis module provides a way to measure Bayer AG's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bayer AG stock.
Bayer |
Bayer AG NA Company Earnings Per Share Analysis
Bayer AG's Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Current Bayer AG Earnings Per Share | 4.78 X |
Most of Bayer AG's fundamental indicators, such as Earnings Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bayer AG NA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Earnings per Share is one of the most critical measures of the firm's current share price and is used by investors to determine the overall company profitability, especially when compared to the EPS of similar companies.
| Competition |
According to the company disclosure, Bayer AG NA has an Earnings Per Share of 4.78 times. This is 42.89% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—General industry. The earnings per share for all Germany stocks is 53.21% lower than that of the firm.
Bayer Earnings Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bayer AG's direct or indirect competition against its Earnings Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Bayer AG could also be used in its relative valuation, which is a method of valuing Bayer AG by comparing valuation metrics of similar companies.Bayer AG is currently under evaluation in earnings per share category among its peers.
Bayer Fundamentals
| Return On Equity | 0.13 | |||
| Return On Asset | 0.0576 | |||
| Profit Margin | 0.09 % | |||
| Operating Margin | 0.23 % | |||
| Current Valuation | 83.74 B | |||
| Shares Outstanding | 982.42 M | |||
| Shares Owned By Institutions | 47.06 % | |||
| Price To Earning | 11.34 X | |||
| Price To Book | 1.37 X | |||
| Price To Sales | 1.00 X | |||
| Revenue | 44.08 B | |||
| Gross Profit | 27.04 B | |||
| EBITDA | 6.45 B | |||
| Net Income | 1000 M | |||
| Cash And Equivalents | 8.19 B | |||
| Cash Per Share | 8.34 X | |||
| Total Debt | 35.55 B | |||
| Debt To Equity | 1.17 % | |||
| Current Ratio | 1.18 X | |||
| Book Value Per Share | 42.01 X | |||
| Cash Flow From Operations | 5.09 B | |||
| Earnings Per Share | 4.78 X | |||
| Price To Earnings To Growth | 1.32 X | |||
| Target Price | 96.0 | |||
| Number Of Employees | 102.3 K | |||
| Beta | 1.17 | |||
| Market Capitalization | 56.05 B | |||
| Total Asset | 120.24 B | |||
| Working Capital | 8.49 B | |||
| Current Asset | 25.17 B | |||
| Current Liabilities | 16.68 B | |||
| Z Score | 0.6 | |||
| Annual Yield | 0.03 % | |||
| Five Year Return | 4.09 % | |||
| Net Asset | 120.24 B | |||
| Last Dividend Paid | 2.0 |
About Bayer AG Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bayer AG NA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bayer AG using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bayer AG NA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Bayer Stock
Bayer AG financial ratios help investors to determine whether Bayer Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bayer with respect to the benefits of owning Bayer AG security.